Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation
Article Details
Journal
Circulation
Volume / Issue
Vol. 151, Issue 3
Published
January 21, 2025
ISSN
0009-7322
Publisher
Lippincott Williams & Wilkins
Related Articles from this Journal
Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations
Johanna Mueller-Leisse, Henrike Aenne Katrin Hillmann et al.
Aug 2026
10.1161/circulationaha.126.080556
Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”
Albert J. Rogers, Sabyasachi Bandyopadhyay et al.
Aug 2026
10.1161/circulationaha.126.080755
Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>
Jennifer E. Ho, Ryan J. Tedford
Aug 2026
10.1161/circulationaha.126.080205
ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction
Yu Liu, Yijin Chen et al.
Aug 2026
10.1161/circulationaha.125.078593
Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”
Dong Li, Shuang Zhang et al.
Aug 2026
10.1161/circulationaha.126.079996